At BIO Asia–Taiwan 2025, the Australia Pavilion brought together 24 leading organizations to highlight Australia’s unique advantages as a clinical trials destination and the technologies transforming the future of drug development. 🇦🇺 Throughout the event, companies demonstrated capabilities in: 🔸 Early-phase and multi-site clinical trial execution 🔸 Biomarker discovery, immunology, and assay development 🔸 DigitalRead More
